News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
526,140 Results
Type
Article (44733)
Company Profile (122)
Press Release (481285)
Section
Business (145220)
Career Advice (2399)
Deals (27969)
Drug Delivery (118)
Drug Development (68237)
Employer Resources (149)
FDA (15632)
Job Trends (11959)
News (264239)
Policy (29644)
Tag
Academia (2290)
Alliances (36018)
Alzheimer's disease (1371)
Approvals (15579)
Artificial intelligence (200)
Bankruptcy (306)
Best Places to Work (9203)
Breast cancer (218)
Cancer (1674)
Cardiovascular disease (139)
Career advice (2000)
CAR-T (123)
Cell therapy (358)
Clinical research (54993)
Collaboration (593)
Compensation (378)
COVID-19 (2582)
C-suite (161)
Data (1560)
Diabetes (218)
Diagnostics (5217)
Earnings (58027)
Employer resources (136)
Events (76481)
Executive appointments (525)
FDA (16557)
Funding (523)
Gene therapy (265)
GLP-1 (729)
Government (3849)
Healthcare (14814)
Infectious disease (2701)
Inflammatory bowel disease (118)
Interviews (449)
IPO (13972)
Job creations (3158)
Job search strategy (1665)
Layoffs (483)
Legal (6952)
Lung cancer (247)
Manufacturing (233)
Medical device (11144)
Medtech (11147)
Mergers & acquisitions (14356)
Metabolic disorders (607)
Neuroscience (1791)
NextGen: Class of 2025 (4993)
Non-profit (3180)
Northern California (2006)
Obesity (345)
Opinion (209)
Patents (175)
People (42441)
Phase I (16454)
Phase II (23830)
Phase III (19531)
Pipeline (778)
Policy (117)
Postmarket research (2221)
Preclinical (6619)
Radiopharmaceuticals (206)
Rare diseases (339)
Real estate (4264)
Regulatory (20690)
Research institute (2058)
Resumes & cover letters (401)
Southern California (1671)
Startups (2750)
United States (16981)
Vaccines (693)
Weight loss (265)
Date
Today (70)
Last 7 days (801)
Last 30 days (2530)
Last 365 days (30869)
2025 (4936)
2024 (31458)
2023 (35059)
2022 (45137)
2021 (48564)
2020 (45568)
2019 (36299)
2018 (27445)
2017 (27860)
2016 (25880)
2015 (28086)
2014 (21857)
2013 (17855)
2012 (19040)
2011 (19443)
2010 (17580)
Location
Africa (671)
Arizona (153)
Asia (30968)
Australia (5434)
California (4467)
Canada (1300)
China (333)
Colorado (199)
Connecticut (229)
Europe (75243)
Florida (675)
Georgia (148)
Illinois (379)
Indiana (210)
Maryland (714)
Massachusetts (3408)
Michigan (161)
Minnesota (283)
New Jersey (1284)
New York (1247)
North Carolina (780)
Northern California (2006)
Ohio (139)
Pennsylvania (988)
South America (1033)
Southern California (1671)
Texas (630)
Utah (125)
Washington State (430)
526,140 Results for "alk abello a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annual General Meeting in ALK-Abelló A/S on 13 March 2025
February 20, 2025
·
1 min read
Press Releases
Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025
February 13, 2025
·
1 min read
Press Releases
ARS Pharmaceuticals Files for Approval of neffy® in Canada and the United Kingdom on Behalf of Licensing Partner ALK-Abelló A/S
January 6, 2025
·
8 min read
Press Releases
ALK’s pivotal phase 3 trial in children published in reputable scientific journal
November 27, 2024
·
6 min read
Press Releases
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity
February 25, 2025
·
7 min read
Press Releases
Invitation to the presentation of ALK’s results for the first nine months (Q3) 2024 on Thursday 14 November 2024
November 7, 2024
·
1 min read
Press Releases
Annual report 2024: ALK delivers 15% sales growth with profits up 65%
February 19, 2025
·
3 min read
Press Releases
U.S. FDA Approves Label Expansion for ALK’s ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy
February 28, 2025
·
10 min read
Press Releases
Invitation to the presentation of ALK’s results for the first six months (Q2) 2024 on Friday 23 August 2024
August 14, 2024
·
1 min read
Business
Annual report 2023: ALK delivers 9% sales growth with profits up 50%
ALK’s ( ALKB:DC / OMX: ALK B / AKBLF ) Board of Directors has approved the company’s 2023 annual report.
February 8, 2024
·
3 min read
1 of 52,614
Next
